Patient support is a key component of CML AllianceTM. In partnership with leading clinicians and patient groups, Novartis has designed two integrated websites designed specifically to help people with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
CML Alliance Patient Support Program: a unique program designed to help improve adherence to therapy and provide access to reimbursement support.
